During the past decade, Michiana Hematology Oncology PC-Crown Point conducted 12 clinical trials. In the 10-year time frame, 12 clinical trials started and 12 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 10 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Michiana Hematology Oncology PC-Crown Point" #1 sponsor was "National Cancer Institute (NCI)" with 9 trials, followed by "SWOG Cancer Research Network" with 6 trials sponsored, "Alliance for Clinical Trials in Oncology" with 3 trials sponsored, "Gynecologic Oncology Group" with 2 trials sponsored and "ECOG-ACRIN Cancer Research Group" with 2 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Michiana Hematology Oncology PC-Crown Point" #1 collaborator was "National Cancer Institute (NCI)" with 13 trials as a collaborator, "NRG Oncology" with 2 trials as a collaborator and "Cancer Prevention Pharmaceuticals, Inc." with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Michiana Hematology Oncology PC-Crown Point" are "Recurrent Squamous Cell Lung Carcinoma" (4 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (3 trials), "Endometrial Serous Adenocarcinoma" (2 trials), "Ovarian Carcinoma" (2 trials) and "Ovarian Serous Adenocarcinoma" (2 trials). Many other conditions were trialed in "Michiana Hematology Oncology PC-Crown Point" in a lesser frequency.

Most popular intervention types in "Michiana Hematology Oncology PC-Crown Point" are "Drug" (19 trials), "Other" (19 trials), "Biological" (6 trials), "Procedure" (3 trials) and "Behavioral" (1 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (13 trials), "Quality-of-Life Assessment" (7 trials), "Docetaxel" (4 trials), "Questionnaire Administration" (4 trials) and "Carboplatin" (3 trials). Other intervention names were less common.

The vast majority of trials in "Michiana Hematology Oncology PC-Crown Point" are 14 trials for "All" genders and 8 trials for "Female" genders.

Currently, there are NaN active trials in "Michiana Hematology Oncology PC-Crown Point". undefined are not yet recruiting, 3 are recruiting, 9 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Michiana Hematology Oncology PC-Crown Point, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Michiana Hematology Oncology PC-Crown Point, 2 "Phase 1" clinical trials were conducted, 9 "Phase 2" clinical trials and 16 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".